BIO-RAD LABORATORIES, INC. Restructuring Reserve, Foreign Currency Translation Gain (Loss)
BIO-RAD LABORATORIES, INC. (BIO) reported Restructuring Reserve, Foreign Currency Translation Gain (Loss) of $2.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-17.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveTranslationAdjustment · last filed 2023-02-17
- BIO-RAD LABORATORIES, INC. restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2017-09-30 was -$200.00K.
- BIO-RAD LABORATORIES, INC. restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2017-06-30 was -$600.00K.
- BIO-RAD LABORATORIES, INC. restructuring reserve, foreign currency translation gain (loss) for the quarter ending 2017-03-31 was -$100.00K.
- BIO-RAD LABORATORIES, INC. restructuring reserve, foreign currency translation gain (loss) for fiscal 2022 was $2.90M, a 6.45% decline from fiscal 2021.
- BIO-RAD LABORATORIES, INC. restructuring reserve, foreign currency translation gain (loss) for fiscal 2021 was $3.10M.
- BIO-RAD LABORATORIES, INC. restructuring reserve, foreign currency translation gain (loss) for fiscal 2016 was $500.00K.
| Period end | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 3 month | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 6 month | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 9 month | Restructuring Reserve, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $2.90M 10-K · filed 2023-02-17 | |||
| 2021-12-31 | $3.10M 10-K · filed 2023-02-17 | |||
| 2017-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$800.00K derived: sum of 2 quarters · filed 2017-11-09 | -$900.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$700.00K 10-Q · filed 2017-08-07 | ||
| 2017-03-31 | -$100.00K 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $500.00K 10-K · filed 2017-03-01 |